UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007487
Receipt number R000008831
Scientific Title Blood-Glucose reduction in Type 2 Diabetes Patients when using two different DPP-4, alogliptin or sitagliptin during 52-week administration
Date of disclosure of the study information 2012/03/20
Last modified on 2012/03/12 10:34:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Blood-Glucose reduction in Type 2 Diabetes Patients when using two different DPP-4, alogliptin or sitagliptin during 52-week administration

Acronym

Blood-Glucose reduction using DPP-4 agents

Scientific Title

Blood-Glucose reduction in Type 2 Diabetes Patients when using two different DPP-4, alogliptin or sitagliptin during 52-week administration

Scientific Title:Acronym

Blood-Glucose reduction using DPP-4 agents

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify reduction levels of Blood glucose using selective DPP-4 inhibitors, alogliptin 25mg or sitagliptin 50mg administered, respectively for 52-week administration.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Reduction value of HbA1c level (JDS) at 12, 24, 36, 52 (terminal) if comparing with at 0 (enrolled)

Key secondary outcomes

Fasting blood glucose
Patient rate completed


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

alogliptin 25mg, tablet, daily, oral
Duration 52 weeks

Interventions/Control_2

sitagliptin 50mg,tablet, daily, oral
Duration 52 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Type 2 diabetes patients having Hba1c with more than 6.5% and under 9.0% for 3 months or more using oral anti-DM drug(s) except for selective DPP-4 inhibitors under diet and/or exercise therapy
1. Gender both, 20 years old or more
2. be able to understood fullly, and comply regarding the study protocol
3. Written informed consent taken prior to the enrollment
4. Outpatients

Key exclusion criteria

1. Type 1 diabetes or secondary diabetes
2. Patients with severe infecious disease, operation planned or just after done, and/or serious externalinjyury
3. Other DPP-4 agents users on the enrollement
4. Insulin users
5. Pregnant and possible pregnant, or Lactation
6. AST or ALT 2.5 times or more of normalvalue
7. Serum creatinine2 mg/dL or more
8. Patients with old myocardial infarction, angina pectoris and/or stroke
9. Patients having history of hypersensitivity against study drugs
10.Inappropriate reasons on the enrollment that the physicians/investigators are judged

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mitsuyoshi Namba

Organization

Hyogo College of Medicine

Division name

Internal medicine, Diabetes

Zip code


Address

1-1, Mukogawa-cho, Nishinomiya City, Hyogo Pf, 663-8501, Japan

TEL

81-1-798-45-6111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroko Usami

Organization

Biomedis International Ltd

Division name

Study Management

Zip code


Address

ASK Ginza Bldg., 10-6-7 Chuo-ku, Tokyo, 104-0061, Japan

TEL

81-1-3-3575-1611

Homepage URL


Email

hiroko-u@biomedis.co.jp


Sponsor or person

Institute

Biomedis International Ltd
Study Management

Institute

Department

Personal name



Funding Source

Organization

Hyogo Colledge of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学(兵庫県)、市立芦屋病院(兵庫県)、県立西宮病院(兵庫県)神戸海星病院(兵庫県)、川崎病院(兵庫県)、協立病院(兵庫県)、渡辺内科クリニック(兵庫県)、
福井医院(兵庫県)、滝内クリニック(兵庫県)、朝田クリニック(兵庫県)
昭和病院(兵庫県)、西宮市立中央病院(兵庫県)、尼崎中央病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2012 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2011 Year 09 Month 16 Day

Date of IRB


Anticipated trial start date

2011 Year 10 Month 01 Day

Last follow-up date

2014 Year 09 Month 01 Day

Date of closure to data entry

2014 Year 09 Month 01 Day

Date trial data considered complete

2014 Year 09 Month 01 Day

Date analysis concluded

2015 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 03 Month 12 Day

Last modified on

2012 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008831


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name